drugset / Trial / NCT00692341
Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the effects of mild and moderate impairment of hepatic function on the single-dose pharmacokinetics, safety and tolerability of AG-013736.
Timeline
- Start
- 2008-05
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | 5 mg | Oral |